Vantage Consulting Group’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $60.6K | Hold |
|
|||||
|
2024
Q4 | $104K | Hold |
|
|||||
|
2024
Q3 | $78.2K | Hold |
|
|||||
|
2024
Q2 | $175K | Hold |
|
|||||
|
2024
Q1 | $460K | Hold |
|
|||||
|
2023
Q4 | $173K | Hold |
|
|||||
|
2023
Q3 | $169K | Hold |
|
|||||
|
2023
Q2 | $528K | Sell |
|
|||||
|
2023
Q1 | $5.44M | Sell |
|
|||||
|
2022
Q4 | $9.7M | Hold |
|
|||||
|
2022
Q3 | $7.88M | Hold |
|
|||||
|
2022
Q2 | $6.4M | Buy |
|
|||||
|
2022
Q1 | $7.28M | Sell |
|
|||||
|
2021
Q4 | $8.54M | Hold |
|
|||||
|
2021
Q3 | $6.19M | Hold |
|
|||||
|
2021
Q2 | $16.1M | Hold |
|
|||||
|
2021
Q1 | $21M | Hold |
|
|||||
|
2020
Q4 | $22.5M | Buy |
|